The carbohydrate-deficient transferrin as a marker of chronic alcohol consumption and assessment of its usefulness in patients with cardiovascular diseases – a pilot study

NOABSTRACTCardiovascular diseases (CVDs) are the leading cause of death in the world. The dose of 60 g of alcohol / day has been estimated to significantly increase the risk of developing high blood pressure, arrhythmias, hemorrhagic stroke, and cardiomyopathy. The aim of the study was to evaluate t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Postȩpy higieny i medycyny doświadczalnej 2023-01, Vol.77 (1), p.91-98
Hauptverfasser:	Waś, Joanna Dominika, Niedolistek, Magdalena, Sokołowska, Dorota, Wiśniewska, Joanna, Zieliński, Tomasz, Mierzyńska, Anna, Rabczenko, Daniel, Orzechowska, Beata, Franz, Dominika, Augustynowicz-Kopeć, Ewa, Lutyńska, Anna
Format:	Artikel
Sprache:	eng
Schlagworte:	alcohol abuse Alcohol use asialotransferrin Biomarkers carbohydrate deficient transferrin CDT Cardiac arrhythmia Cardiology Cardiomyopathy Cardiovascular disease disialotransferrin Ejection fraction GGT (Gamma-Glutamyl Transferase) Heart failure Hypertension Ischemia Mortality Patients Peptides Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	NOABSTRACTCardiovascular diseases (CVDs) are the leading cause of death in the world. The dose of 60 g of alcohol / day has been estimated to significantly increase the risk of developing high blood pressure, arrhythmias, hemorrhagic stroke, and cardiomyopathy. The aim of the study was to evaluate the diagnostic value of CDT when compared with gammaglutamyltransferase (GGT), alkaline phosphatase (ALP), N-terminal fragment brain natriuretic peptide (NT pro-BNP) and troponin T biomarkers in patients with heart failure.The study was conducted on 59 patients with advanced heart failure with reduced ejection fraction (EF
ISSN:	1732-2693 0032-5449 1732-2693
DOI:	10.2478/ahem-2023-0010